Measurement and analysis of unbound drug concentrations

Clinical Pharmacokinetics

Volumn 30, Issue 6, 1996, Pages 445-462

  Wright, Jennifer D ^a   Boudinot, F Douglas ^a   Ujhelyi, Michael R ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; COMPUTER ANALYSIS; DRUG BINDING SITE; DRUG BLOOD LEVEL; DRUG CONCENTRATION; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG MONITORING; DRUG PROTEIN BINDING; EQUILIBRIUM DIALYSIS; MEASUREMENT; METHODOLOGY; MICRODIALYSIS; PHARMACOKINETICS; PLASMA PROTEIN BINDING; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVIEW; SCATCHARD PLOT; ULTRAFILTRATION;

EID: 0029889951     PISSN: 03125963     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003088-199630060-00003     Document Type: Review

References (142)

1. Benet LZ, Massoud N. Pharmacokinetics. In: Benet LZ, Massoud N, Gambertoglio JG, editors. Pharmacokinetic basis for drug treatment. New York: Raven Press, 1984: 1-28
2. Wilkinson GR. Clearance approaches in pharmacology. Pharmacol Rev 1987; 39: 1-47
3. Ujhelyi MR, Colucci RD, Cummings DM, et al. Monitoring serum digoxin concentrations during digoxin FAB therapy. DICP 1991; 25: 1047-9
4. Ujhelyi MR, Robert S, Cummings DM, et al. Influences of digoxin fab antibody therapy and renal dysfunction on the disposition of total and unbound digoxin. Ann Intern Med 1993; 119: 273-7
5. Blum MR, Riegelman S, Becker CE. Altered protein binding of diphenylhydantoin in uremic plasma. New Engl J Med 1972; 286: 109
6. Odar-Cederlof I, Lunde P, Sjogvist F. Abnormal pharmacokinetics of phenytoin in a patient with uremia. Lancet 1970; 11: 831-2
7. Gibaldi M, Koup JR. Pharmacokinetic concepts-drug binding, apparent volume of distribution and clearance. Eur J Clin Pharmacol 1981; 20: 299-305
8. Kunin CM, Craig WA, Kornguth M, et al. Influence of protein binding on the pharmacologic activity of antibiotics. Ann N Y Acad Sci 1973; 296: 214-34
9. Perucca E. Free level monitoring of antiepileptic drugs: clinical usefulness and case studies. Clin Pharmacokinet 1984; 9 Suppl. 1: 71-8
10. Perucca E, Grimaldi R, Crema A. Interpretation of drug levels in acute and chronic disease states. Clin Pharmacokinet 1985; 10: 498-513
11. Rowland M, Tozer TN. Clinical pharmacokinetics, concepts and applications. Pennsylvania: Williams & Wilkins, 1995: 142-3
12. Jusko WJ, Gretch M. Plasma and tissue protein binding of drugs in pharmacokinetics. Drug Metab Rev 1976; 5: 43-140
13. Peters Jr T. Serum albumin. In: Putman F, editor. The plasma proteins. Vol. 1. New York: Academic Press, 1975: 133-81
14. Kragh-Hausen U. Molecular aspects of ligand binding to serum albumin. Pharmacol Rev 1981; 33: 17-53
15. Kremer JMH, Wilting J, Janssen LHM. Drug binding of human alpha-1-acid glycoprotein in health and disease. Pharmacol Rev 1988; 40: 1-47
16. Lemaire M, Urien S, Albengres E, et al. Lipoprotein binding of drugs. In: Reidenberg MM, Erill S, editors. Drug-protein binding. New York: Praeger Publishers, 1986: 36-45
17. Shargel L, Yu ABC. Applied biopharmaceutics and pharmacokinetics. Connecticut: Appleton & Lange, 1993: 92-4
18. Woo J, Chan HS, Or KH, et al. Effect of age and disease on two drug binding proteins: albumin and alpha-1-acid glycoprotein. Clin Biochem 1994; 27: 289-92
19. Caswell M, Pike LA, Bull BS, et al. Effect of patient age on tests of acute-phase response. Arch Pathol Lab Med 1993; 117: 906-10
20. Crook MA, Treloar A, Haq M, et al. Serum total sialic acid and other acute phase protons in elderly subjects. Eur J Clin Chem Clin Biochem 1994; 32: 745-7
21. Lalonde RL, Tenero DM, Burlew BS, et al. Effects of age on the protein binding and disposition of propranolol stereoisomers. Clin Pharmacol Ther 1990; 47: 447-55
22. Veering BT, Burm AG, Souverijn JH, et al. The effect of age on serum concentrations of albumin and alpha 1-acid glycoprotein. Br J Clin Pharmacol 1990; 29: 201-6
23. Ecoffey C. Pharmacokinetics of local anesthetics in children. Cah Anesthesiol 1992; 40: 533-6
24. Seta N, Tissot B, Forestier F, et al. Changes in alpha 1-acid glycoprotein serum concentrations and glycoforms in the developing human fetus. Clin Chim Acta 1994; 203: 167-75
25. Meistelman C, Benhamou D, Barre J, et al. Effects of age on plasma protein binding of sufentanil. Anesthesiology 1990; 72: 470-3
26. Bardy AH, Hiilesmaa VK, Teramo K, et al. Protein binding of antiepileptic drugs during pregnancy, labor and puerperium. Ther Drug Monit 1990; 12: 40-6
27. Notarianni LJ. Plasma protein binding of drugs in pregnancy and in neonates. Clin Pharmacokinet 1990; 18: 20-36
28. Mather JE, Goldenberg RL, Tamura T, et al. Albumin levels in pregnancy: a hypothesis-decreased levels of albumin are related to increased levels of alpha-fetoprotein. Early Hum Dev 1993; 34: 209-15
29. Gleichmann W, Backmann GW, Dengler HJ, et al. Effect of hormonal contraceptives and pregnancy on serum protein pattern. Eur J Clin Pharmacol 1973; 5: 218-25
30. Routledge PA, Stargel WW, Kithell BB, et al. Sex-related differences in the plasma protein binding of lidocaine and diazepam. Br J Clin Pharmacol 1981; 11: 245-50
31. Song CS, Merkatz IR, Rifkind AB, et al. The influence of pregnancy and oral contraceptive steroids on the concentration of plasma proteins. Amer J Obstet Gynec 1970; 108: 227-31
32. 1-acid glycoprotein in moderately obese male subjects. Br J Clin Pharmacol 1984; 18: 941-6
33. 1-acid glycoprotein and the binding of drugs in obesity. Br J Clin Pharmacol 1983; 16: 751-4
34. DeVore PA. Assessment of nutritional status and obesity in elderly patients as seen in general medical practice. South Med J 1993; 86: 1008-10
35. Girardin E, Bruguerolle B. Pharmacokinetic changes in obesity. Therapie 1993; 48: 397-402
36. Le Devehat C, Khodabandehlou T, Dougny M. Hemorheological parameters in isolated obesity. Diabete Metab 1992; 18: 43-7
37. Ziolkowski M, Korzybska D, Rybakowski J. Plasma proteins as biochemical markers of alcohol abuse. Psychiatr Pol 1994; 28: 51-9
38. Lippi G, Fedi S, Grassi M, et al. Acute phase proteins in alcoholics with or without liver injury. Ital J Gastroenterol 1992; 24: 383-5
39. Dales LG, Friedman GD, Siegelaub AB, et al. Cigarette smoking and serum chemistry tests. J Chronic Dis 1974; 27: 293-307
40. Moszczynski P, Moszczynski Jr P, Slowinski S. Indicators of humoral immunity and acute phase reaction in cigarette smokers. Pol Arch Med Wewn 1990; 83: 194-9
41. Macuie AG, Magides AD, Reilly CS. Disposition of alfentanil in burns patients. Br J Anaesth 1992; 69: 447-50
42. Pos O, van der Stell ME, Wolbink GJ, et al. Changes in the serum concentration and the glycosylation of human alpha 1-acid glycoprotein and alpha 1-protease inhibitor in severely burned persons: relation to interleukin-6 levels. Clin Exp Immunol 1990; 82: 579-82
43. Bonate PL. Pathophysiology and pharmacokinetics following burn injury. Clin Pharmacokinet 1990; 18: 118-30
44. Niwa Y, Iio A, Niwa G, et al. Serum albumin metabolism in rheumatic diseases: relationship to corticosteroids and peptic ulcer. J Clin Lab Immunol 1990; 31: 11-6
45. Nahaczewska W, Kudrewicz Hubicka Z, Owzarek H, et al. Concentration of acute phase proteins in serum of children with rheumatoid arthritis. Wiad Lek 1993; 46: 906-11
46. Lacki JK, Porawska W, Mackiewicz SH, et al. Acute-phase response in early refractory theumatoid arthritis: long-lerm follow-up study. J Investig Allergol Clin Immunol 1994; 4: 168-71
47. Majewski W, Zielinski A, Laciak M, et al. C-reactive protein and alpha-1-acid glycoprotein in monitoring of patients with chronic arterial occlusion of the lower limbs. Eur J Vasc Surg 1993; 7: 628-32
48. Majewski W, Laciak M, Staniszewski R, et al. C-reactive protein and alpha 1-acid glycoprotein in monitoring of patients with acute arterial occlusion. Eur J Vasc Surg 1991; 5: 641-5
49. Mori T, Sasaki J, Kawaguchi H, et al. Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J 1995; 129: 234-8
50. Kwan T, Pintea M, Garcia-Morino F, et al. Transcapillary oncotic pressure in the edema of congestive heart failure. Nephron 1990; 54: 21-5
51. Nomura A, Yasuda H, Kobayashi T, et al. Serum alpha-1-acid glycoprotein and protein binding of disopyramide in patients with congestive heart failure. Eur J Clin Pharmacol 1992; 42: 115-6
52. David BM, Ilett KF, Witford EG, et al. Prolonged variability in plasma protein binding of disopyramide after acute myocardial infarction. Br J Clin Pharmacol 1983; 15: 435-41
53. Andreassen AK, Berg K, Torsvik H. Changes in Lp(a) lipoprotein and other plasma proteins during acute myocardial infarction. Clin Genet 1994; 46: 410-6
54. Crook M, Haq M, Haq S, et al. Plasma sialic acid and acute-phase proteins in patients with myocardial infarction. Angiology 1994; 45: 709-15
55. Birke G, Liljedahl SO, Plantin LO, et al. Albumin catabolism in burns and following surgical procedures. Acta Chir Scand 1959-1960; 118: 353-66
56. Eap CB, Fischer JF, Baumann P. Variations in relative concentrations of variants of human alpha 1-acid glycoprotein after acute phase conditions. Clin Chim Acta 1991; 203: 379-85
57. Kushner I, Mackiewicz A. Acute phase proteins as disease markers. Dis Markers 1987; 5: 1-11
58. Boosalis MG, Gray D, Walker S, et al. The acute phase response in autologous bone marrow transplantation. J Med 1992; 23: 175-93
59. Gurlich R, Maruna P, Cermak J, et al. Early diagnosis of septic complications in the postoperative period by determination of acute phase proteins. Rozhl Chir 1993; 72: 235-8
60. Petermann ML. Alterations in plasma protein patterns in disease. In: Putman F, editor. The plasma proteins. Vol. 2. Biosynthesis, metabolism, alterations in disease. New York: Academic Press, 1960: 309-43
61. Filteau SM, Morris SS, Tomkins AM, et al. Lack of association between vitamin A status and measures of conjunctival epithelial integrity in young children in northern Ghana. Eur J Clin Nutr 1994; 48: 669-77
62. Takaishi M, Sadamoto K, Takami S, et al. Change in various serum protein levels between acute and convalescent phases in patients with respiratory infections. Nippon Kyobu Shikkan Gakkai Zasshi 1990; 28: 315-9
63. Odelowo EO. Mantoux test tuberculin reaction in Nigerians. Afr J Med Med Sci 1994; 23: 91-8
64. Suzuki K, Takashima Y, Yamada T, et al. The sequential changes of serum acute phase reactants in response to antituberculosis chemotherapy. Kekkaku 1992; 67: 303-11
65. Immanuel C, Acharyulu GS, Kannapiran M, et al. Acute phase proteins in tuberculous patients. Indian J Chest Dis Allied Sci 1990; 32: 15-23
66. Graninger W, Thalhammer F, Hollenstein U, et al. Serum protein concentrations in plasmodium falciparum malaria. Acta Trop 1992; 52: 121-8
67. Wanwimolruk S, Denton JR. Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria. J Pharm Pharmacol 1992; 44: 806-11
68. Mansor SM, Molyneux ME, Taylor TE, et al. Effect of Plasmodium falciparum malaria infection on the plasma concentration of alpha 1-acid glycoprotein and the binding of quinine in Malawian children. Br J Clin Pharmacol 1991; 32: 317-21
69. Onizuka K, Migita S, Vamada H, et al. Studies on serum protein fractions of patients with uterine cervical cancer undergoing radiotherapy: relationship between changes in serum protein fractions and prognosis. Nippon Igaku Hoshasen Gakkai Zasshi 1994; 54: 1007-17
70. Raveendran R, Heybroek WM, Caulfield M, et al. Protein binding of indomethacin, methotrexate and morphine in patients with cancer. Int J Clin Pharmacol Res 1992; 12: 117-22
71. Pelliniemi TT, Irjala K, Mattila K, et al. Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group. Blood 1995; 85: 765-71
72. Xie JF. Clinical significance of serum ferritin and acute phase reactant proteins levels in patients with cervical cancer. Chung Hua Fu Chan Ko Tsa Chih 1991; 26: 92-4
73. Putzki H, Hagner O. Sensitivity and specificity of alpha-1-antitrypsin and acid alpha-1-glycoprotein in colorectal carcinoma. Gastroenterol J 1991; 51: 104-7
74. Jensen H, Rossing N, Andersen SB, et al. Albumin metabolism in the nephrotic syndrome in adults. Clin Sci 1967; 33: 445-57
75. Arredondo G, Martinez-Jorda R, Calvo R, et al. Protein binding of itraconazole and fluconazole in patients with chronic renal failure. Int J Clin Pharmacol Ther 1994; 32: 361-4
76. Vasson MP, Baguet JC, Arveiller MR, et al. Serum and urinary alpha-1 acid glycoprotein in chronic renal failure. Nephron 1993; 65: 299-303
77. Movin OG, Boelaert J, Hammarlund Udenaes M, et al. The pharmacokinetics of remoxipride and metabolites in patients with various degrees of renal function. Br J Clin Pharmacol 1993; 35: 615-22
78. Vasson MP, Paul JL, Couderc R, et al. Serum alpha-1 acid glycoprotein in chronic renal failure and hemodialysis. Int J Artif Organs 1991; 14: 92-6
79. Sunderman FW. Recent advances in clinical interpretation of electrophoretic fractionations of the serum proteins. In: Sunderman FW, Sunderman FW Jr, editors. Serum proteins and the dysproteinemias. Philadelphia: Lippincott, 1964: 323-45
80. Godl I, Muller C, Wolf H, et al. Acute phase reaction in acute viral hepatitis. Padiatr Padol 1990; 25: 147-55
81. 1-acid glycoprotein: implications for binding of drugs. Ther Drug Monit 1986; 8: 259-63
82. Garcia-Morillas M, Gil-Extremera B, Caracuel-Ruiz MD. Differential effects of hepatic cirrhosis on the plasma protein binding of drugs. Int J Clin Pharm Res 1984; 4: 327-33
83. Hallen J, Laurell CB. Plasma protein pattern in cirrhosis of the liver. Scand J Clin Lab Invest 1972; 20: 97-103
84. Kindmark CO, Laurell CB. Sequential changes of the plasma protein pattern in inoculation hepatitis. Scand J Clin Lab Invest 1972; 20: 105-15
85. Joelsson B, Alwmark A, Gullstrand P, et al. Serum proteins in liver cirrhosis: effects of shunt surgery. J Clin Chem Clin Biochem 1987; 25: 865-8
86. 1-acid glycoprotein in two benign liver diseases: alcoholic cirrhosis and acute hepatitis. Clin Chim Acta 1989; 186: 59-66
87. Falleti E, Pirisi M, Fabris C, et al. Increase of serum alpha 1-acid glycoprotein despite the decline of liver synthetic function in cirrhotics with hepatocellular carcinoma. Eur J Clin Chem Clin Biochem 1993; 31: 407-11
88. Viani A, Rizzo G, Carrai M, et al. Interindividual variability in the concentrations of albumin and alpha-1-acid glycoprotein in patients with renal or liver disease, newborns and healthy subjects: implications for binding of drugs. Int J Clin Pharmacol Ther Toxicol 1992; 30: 128-33
89. Fukazawa H, Sakurada T, Tamura K, et al. The influence of immunosupressive acidic protein on the activity of peripheral K-lymphocytes in subacute thyroiditis. J Clin Endocrinol Metab 1990; 71: 193-8
90. Jira L, Banovac K, Petek M, et al. Competitive ligand-binding assay for thyroxine binding globulin. Ann Endocrinol (Paris) 1979; 40: 487-94
91. Gwilt PR, Nahhas RR, Tracewell WG. The effects of diabetes mellitus on pharmacokinetics and pharmacodynamics in humans. Clin Pharmacokinet 1991; 20: 477-90
92. O'Byrne S, Barry MG, Collins WC, et al. Plasma protein binding of lidocaine and warfarin in insulin-dependent and non-insulin-dependent diabetes mellitus. Clin Pharmacokinet 1993; 24: 183-6
93. Song C, Dinan T, Leonard BE. Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls. J Affect Disord 1994; 30: 283-8
94. Maes M, Scharpe S, Bosmans E, et al. Disturbances in acute phase plasma proteins during melancholia: additional evidence for the presence of an inflammatory process during that illness. Prog Neuropsychopharmacol Biol Psychiatry 1992; 16: 501-15
95. Maes M, Scharpe S, Van Grootel L, et al. Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness. J Affect Disord 1992; 24: 183-92
96. Healy D, Calvin J, Whitehouse AM, et al. Alpha-1-acid glycoprotein in major depressive and eating disorders. J Affect Disord 1991; 22: 13-20
97. Kehoe WA, Kwentus JA, Sheffel WB, et al. Increased alpha-1-acid glycoprotein in depression lowers free fraction of imipramine. Biol Psychiatry 1991; 29: 489-93
98. Nemeroff CB, Krishnan KR, Blazer DG, et al. Elevated plasma concentrations of alpha 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients. Arch Gen Psychiatry 1990; 47: 337-40
99. Casey EA, Gilbert FE, Gravice JF, et al. Low urea-nitrogen and elevated serum albumin in anxiety neuroses and psychoses. Ala J Med Sci 1971; 8: 168-77
100. Sen DK, Sarin GS, Ghosh B, et al. Serum alpha-1 acid glycoprotein levels in patients with idiopathic peripheral retinal vasculitis (Eales' disease). Acta Ophthalmol (Copenh) 1992; 70: 515-7
101. Gupta AK, Sarin GS, Rastogi A, et al. Serum alpha-1 acid glycoprotein levels in acute idiopathic anterior uveitis. Ann Ophthalmol 1991; 23: 406-9
102. Steffes C, Fromm D. Is preoperative parenteral nutrition necessary for patients with predominantly ileal Crohn's disease? Arch Surg 1992; 127: 1210-2
103. Novacek G, Vogelsang H, Schmidt B, et al. Are single measurements of pseudocholinesterase and albumin markers for inflammatory activity or nutritional status in Crohn's disease? Wien Klin Wochenschr 1993; 105: 111-5
104. Gesink van der Veer BJ, Burm AG, Vletter AA, et al. Influence of Crohn's disease on the pharmacokinetics and pharmacodynamics of alfentanil. Br J Anaesth 1993; 71: 827-34
105. Vucelic B, Milicic D, Krznaric Z, et al. Serum acute phase proteins for determining disease activity of ulcerative colitis and Crohn disease. Acta Med Austriaca 1991; 18: 100-5
106. Domschke S, Malfertheiner P, Uhl W, et al. Free fatty acids in serum of patients with acute necrotizing or edematous pancreatitis. Int J Pancreatol 1993; 13: 105-10
107. McKay C, Beastall GH, Imrie CW, et al. Circulating intact parathyroid hormone levels in acute pancreatitis. Br J Surg 1994; 81: 357-60
108. De la Pena J, De las Heras G, Galo Peralta F, et al. Prospective study of the prognostic value of C reactive protein, alpha 1-antitrypsin and alpha 1-acid glycoprotein in acute pancreatitis. Rev Esp Enferm Dig 1991; 79: 337-40
109. Hestnes A, Stovner LJ, Husoy O, et al. Hormonal and biochemical disturbances in Down's syndrome. J Ment Defic Res 1991; 35: 179-93
110. Oda M, Hakamada R, Ono K, et al. A seroimmunological analysis of Down syndrome. Gerontology 1993; 39 Suppl. 1: 16-23
111. Bartelik S. Concentration of serum proteins in children with down syndrome. Wiad Lek 1992; 45: 682-5
112. Adeodu OO, Adekile AD. Clinical and laboratory features associated with persistent gross splenomegaly in Nigerian children with sickle cell anaemia. Acta Paediatr Scand 1990; 79: 686-90
113. Rivero RA, Macias C, del Valle L, et al. Immunologic changes in sickle-cell anemia. Sangre (Barc) 1991; 36: 15-20
114. Warrier RP, Kubividila S, Gordon L, et al. Transport proteins and acute phase reactant proteins in children with sickle cell anemia. J Natl Med Assoc 1994; 86: 33-9
115. Hedo CC, Aken'ova YA, Okpala IE, et al. Acute phase reactants and severity of homozygous sickle cell disease. J Intern Med 1993; 233: 467-70
116. Monnet D, Diallo I, Sangare A, et al. Clinical value of C-reactive protein, alpha 1-glycoprotein acid and transferrin assay in homozygous sickle cell disease. Bull Soc Pathol Exot 1993; 86: 282-5
117. Mohammed SS, Christopher MM, Mehta P, et al. Increased erythrocyte and protein binding of codeine in patients with sickle cell disease. J Pharm Sci 1993; 82: 1112-7
118. Morita K, Yamaji A. Changes in the concentration of serum alpha 1-acid glycoprotein in epileptic patients. Eur J Clin Pharmacol 1994; 46: 137-42
119. Meijer C, Huysen V, Smeenk RT, et al. Profiles of cytokines (TNF alpha and IL-6) and acute phase proteins (CRP and alpha 1AG) related to the disease course in patients with systemic lupus erythematosus. Lupus 1993; 2: 359-65
120. Cirasino L, Landonio G, Imbriani M. Hypoalbuminemia in human immunodeficiency virus infection: causes and possible prognostic value. J Parent Enter Nutr 1993; 17: 101-2
121. Suttmann U, Ockenga J, Selberg O, et al. Incidence and prognostic value of malnutrition and wasting in human immunodeficiency virus-infected outpatients. J Acquir Immune Defic Syndr Hum Retrovirol 1995; 8: 239-46
122. Cordiali FP, Massa A, Prignano G, et al. Behaviour of several 'progession markers' during the HIV-Ab seroconversion period. Comparison with later stages. J Biol Regul Homeost Agents 1992; 6: 57-64
123. Monnet D, Kacou E, Gershy Damet GM, et al. Inflammatory reaction markers and nutritional markers in HIV infection. Ann Biol Clin (Paris) 1991; 49: 428-32
124. Hayes MJ, Torzillo PJ, Sheil AG, et al. Pneumocystis carinii pneumonia after liver transplantation in adults. Clin Transplant 1994; 8: 499-503
125. Mackiewicz A, Khan MA, Gorny A, et al. Glycoforms of alpha 1-acid glycoprotein in sera of human immunodeficiency virus-infected persons. J Infect Dis 1994; 169: 1360-3
126. Kurz H, Trunk H, Wertz B. Evaluation of methods to determine protein binding of drugs. Arzneimittelforschung 1977; 27: 1373-80
127. Chignell CU. Protein binding. In: Garnett ER, Hirtz JL, editors. Drug fate and metabolism. Vol 1. New York: Marcel Dekker, 1977: 187-228
128. Bowers WF, Fulton S, Thompson J. Ultrafiltration vs equilibrium dialysis for determination of free fraction. Clin Pharmacokinet 1984; 9: 49-60
129. Pacifici GM, Viani A. Methods of determining plasma and tissue binding of drugs: pharmacokinetic consequences. Clin Pharmacokinet 1992; 23: 449-68
130. Muller M, Schmid R, Georgopoulos A, et al. Application of microdialysis to clinical pharmacokinetics in humans. Clin Pharmacol Ther 1995; 57: 371-80
131. Schentag JJ, Ballow CH. Tissue-directed pharmacokinetics Am J Med 1991; 91 Suppl. 3A: 5-11
132. Craig WA, Welling PG. Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications. Clin Pharmacokinet 1977; 2: 252-68
133. Riva R, Albani F, Baruzzi A, et al. Determination of unbound valproic acid concentration in plasma by equilibrium dialysis and gas-liquid chromatography: methodological aspects in epileptic patients. Ther Drug Monit 1982; 4: 341-52
134. Boudinot FD, Jusko WJ. Fluid shifts and other factors affecting plasma protein binding of prednisolone by equilibrium dialysis. J Pharm Sci 1984; 73: 774-80
135. Oppenheimer JH, Surks MI. Determination of free thyroxine in human serum: a theoretical and experimental analysis. J Clin Endocrinol Metab 1964; 24: 785-93
136. Lima JJ, McKichan JJ, Libertin N, et al. Influence of volume shifts on drug binding during equilibrium dialysis: correlation and attenuation. J Pharmacokinet Biopharm 1983; 11: 483-98
137. Judd RL, Pesce AJ. Free drug concentrations are constant in serial fractions of plasma ultrafiltrate. Clin Chem 1982; 28: 1726-7
138. Whitlam JB, Brown KF. Ultrafiltration in serum protein binding determinations. J Pharm Sci 1981; 70; 146-50
139. Fan C, Tisdale JR, Ujhelyi MR, et al. Underprediction of unbound quinidine concentration as determined by ultrafiltration. Clin Pharm 1993; 12: 917-21
140. Rose JQ, Yurchak AM, Jusko WJ. Dose dependent pharmacokinetics of prednisone and prednisolone in man. J Pharmacokinet Biopharm 1981; 9: 389-417
141. Boxenbaum HG, Riegelman S, Elashoff RM. Statistical estimations in pharmacokinetics. J Pharmacokinet Biopharm 1974; 2: 123-48
142. Yamaoka K, Nakagawa T, Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978; 6: 165-75